Product Catalog
Manufacturer: BioTissue
Ocular Surface Repair + Protection, Ophthalmology
AmnioGraft 3.5 x 3.5cm
Item #: AG-3535FManufacturer: BioTissue
A vision of regenerative healing.
AmnioGraft®, a cryopreserved amniotic membrane graft, supports accelerated post-op recovery and ensures superior patient outcomes when used in ocular surface reconstructive procedures.1,6-7,9
The biologic ocular transplantation tissue grafts help your patient heal better and faster. BioTissue’s CryoTek® cryopreserved amniotic membrane products are the only amniotic membrane grafts cleared by the FDA for their therapeutic properties in repairing and healing ocular surface inflammation.4
AmnioGraft improves surgical outcomes for a variety of indications including:
- Pterygium
- Mechanical dry eye (CCh)
- Corneal defects
- High-risk trabeculectomies
- Leaking glaucoma blebs
- Chemical burns
- Stevens-Johnson Syndrome
- Strabismus
- Removal of tumors
- Promote Regenerative Healing: AmnioGraft helps create a healing environment that is conducive to more effective healing of the ocular surface, and improved clinical outcomes.
- Expedite Recovery: Post-op recovery time is accelerated, as AmnioGraft reduces inflammation and promotes rapid healing, typically in 2-3 weeks.5-11
-
Less Recurrence: A recent study of over 280 patients showed a recurrence rate of less than 1% after surgical excision of primary, single-headed pterygium with cryopreserved AM.5
- AmnioGraft is supplied in an easy-to-use dual peel pouch. Use sterile smooth forceps or gloves to remove the inner pouch containing the tissue. The clear inner pouch may be introduced to the sterile field. Using sterile scissors, cut below the sealed line of the inner pouch and remove AmnioGraft using smooth sterile forceps. Once retrieved from the sterile, clear inner pouch, AmnioGraft can be easily removed from its carrier paper using a dry surgical sponge or 0.12 forceps.
- The tissue is ready for transplantation immediately after removing it from the carrier paper without the need for rehydration.
- AmnioGraft is always manufactured with the stromal side of the tissue attached to the carrier paper. It is easy to determine the orientation of AmnioGraft after it has been removed from its carrier paper using a dry surgical sponge. The dry sponge will stick to the stromal side, but it will not stick to the basement membrane side.
- Location and Temperature: -80°C → 4°C (-112°F → 39.2°F).
- Shelf Life: Within the expiration date printed on product packaging (2 years from date of manufacture).
- 1. Solomon A, Pires RTF and Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108: 449-60.
-
4. Tighe S, Mead O, Lee A and Tseng S. Basic Science Review of Birth Tissue Uses in Ophthalmology. Taiwan Journal of Ophthalmology. 2020; 10.
- 5. Desai N. Outcomes of Tissuetuck Surgery for Primary Pterygium. Paper. 2022 ASCRS ASOA Annual Meeting
-
6. Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis. Cornea. 2007;26(6):685-691.
- 7. Kheirkhah A, Casas V, Blanco G, Li W, Hayashida Y, Chen YT, Tseng SC. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am J Ophthalmol. 2007;144(2):311-3.
- 9. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane. Cornea. 2001; 20(6):619-621.
- Open Market